NCERT's summary says that gene therapy can work "by replacing a defective mutant allele with a functional one". In ADA deficiency, however, the gene for ADA is deleted. In the first clinical gene therapy for this disorder, which statement correctly describes what was done to the patient's lymphocytes?
Practice Questions · Question 5 of 30
NCERT's summary says that gene therapy can work "by replacing a defective mutant allele with a functional one".
- Correct answer
(A) A functional ADA cDNA was added to the lymphocytes, where it takes over the function of, and compensates for, the missing gene; nothing was cut out of their DNA.
(B) The deleted stretch of the lymphocytes' DNA was rebuilt at its original position, so that the lymphocytes regained their own ADA gene.
(C) The defective ADA allele was cut out of the lymphocytes' DNA and replaced by a functional allele at exactly the same position.
(D) The lymphocytes were given the functional ADA enzyme, which then made new copies of the ADA gene inside the cells.
Option (A) is correct.
Explanation: NCERT: "Correction of a genetic defect involves delivery of a normal gene into the individual or embryo to take over the function of and compensate for the non-functional gene." In ADA deficiency there is no mutant allele to replace, because the gene is deleted. Lymphocytes from the patient's blood are grown in culture, a functional ADA cDNA is introduced into them with a retroviral vector, and they are returned to the patient. The added cDNA supplies the missing function.
- (B) Nothing is rebuilt at the original position; a separate copy (cDNA) is delivered into the cells.
- (C) There is no defective allele to cut out, since the gene is deleted.
- (D) An enzyme cannot make a gene. Giving the enzyme is enzyme replacement therapy, a different treatment.
